BUY SDB-005 DRUG ONLINE

Product Code: BUY SDB-005 DRUG ONLINE
Availability: In Stock

210

Available Options
  • $210.00




BUY SDB-005 DRUG ONLINE

Description

BUY SDB-005 DRUG ONLINE powder wholesale from the manufacturer, high quality at a low price with shipping worldwide. SDB-005 is an indazole-based synthetic cannabinoid


SDB-005 powder with the systematic or IUPAC name of 1-(5-Fluoro-pentyl)-1H-indazole-3-carboxylic acid naphthalen-1-yl ester is an analog of SDB-006. The molecular formula for 5F-SDB-005 is C23H21FN2O2 with a molecular weight of 376.42 and an exact mass of 376.16.


CAS: 99312-12-2

Formula: C23H21FN2O2

Purity: 99,7% min

Molecular weight: 376.42

Appearance:: Powder


SDB-005 is an indazole-based synthetic cannabinoid that has been sold online as a designer drug. It is presumed to be an agonist of the CB1 and CB2 cannabinoid receptors. SDB-005 is the indazole core analogue of PB-22 where the 8-hydroxyquinoline has also been replaced with a naphthalene group.


The code number SDB-005 was originally used for a different compound, the N-phenyl instead of N-benzyl analogue of SDB-006. This compound is a potent agonist of the CB1 receptor (Ki = 21 nM) and CB2 receptor (Ki = 140 nM).


It is presumed to be an agonist of the CB1 and CB2 cannabinoid receptors. SDB-005 is the indazole core analogue of PB-22 where the 8-hydroxyquinoline has also been replaced with a naphthalene group.


SDB-005 with the systematic or IUPAC name of 1-(5-Fluoro-pentyl)-1H-indazole-3-carboxylic acid naphthalen-1-yl ester is an analog of SDB-006. The molecular formula for 5F-SDB-005 is C23H21FN2O2 with a molecular weight of 376.42 and an exact mass of 376.16.


SDB-005 is an indazole-based synthetic cannabinoid that has been sold online as a designer drug. It is presumed to be an agonist of the CB1 and CB2 cannabinoid receptors. SDB-005 is the indazole core analogue of PB-22 where the 8-hydroxyquinoline has also been replaced with a naphthalene group.


The code number SDB-005 was originally used for a different compound, the N-phenyl instead of N-benzyl analogue of SDB-006. This compound is a potent agonist of the CB1 receptor (Ki = 21 nM) and CB2 receptor (Ki = 140 nM).


It is presumed to be an agonist of the CB1 and CB2 cannabinoid receptors. SDB-005 is the indazole core analogue of PB-22 where the 8-hydroxyquinoline has also been replaced with a naphthalene group.

Note: HTML is not translated!